A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies
…, GS Dizerega, MJ Baltezor, J Espinosa… - Cancer chemotherapy …, 2015 - Springer
Purpose This multicenter, open-label, dose-escalating, phase I study evaluated the safety,
tolerability, pharmacokinetics and preliminary tumor response of a nanoparticulate …
tolerability, pharmacokinetics and preliminary tumor response of a nanoparticulate …
Tyr1-ψ[(Z)CF═CH]-Gly2 Fluorinated Peptidomimetic Improves Distribution and Metabolism Properties of Leu-Enkephalin
…, LG Rajewski, PC Toren, MJ Baltezor… - ACS chemical …, 2018 - ACS Publications
Opioid peptides are key regulators in cellular and intercellular physiological responses, and
could be therapeutically useful for modulating several pathological conditions. Unfortunately…
could be therapeutically useful for modulating several pathological conditions. Unfortunately…
Preclinical pharmacokinetics of fosciclopirox, a novel treatment of urothelial cancers, in rats and dogs
…, M Dalton, GA Reed, RA Jensen, MJ Baltezor… - … of Pharmacology and …, 2019 - ASPET
Pharmacokinetic studies in rats and dogs were performed to characterize the in vivo
performance of a novel prodrug, fosciclopirox. Ciclopirox olamine (CPX-O) is a marketed topical …
performance of a novel prodrug, fosciclopirox. Ciclopirox olamine (CPX-O) is a marketed topical …
[HTML][HTML] Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex
…, W McCulloch, M Dalton, GA Reed, MJ Baltezor… - Cell Death & …, 2021 - nature.com
Ciclopirox (CPX) is an FDA-approved topical antifungal agent that has demonstrated preclinical
anticancer activity in a number of solid and hematologic malignancies. Its clinical utility …
anticancer activity in a number of solid and hematologic malignancies. Its clinical utility …
[HTML][HTML] Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression …
…, HA Maulhardt, SJ Verco, AM Marin, MJ Baltezor… - Oncology and …, 2024 - Springer
This review summarizes development of large surface area microparticle paclitaxel (LSAM-PTX)
and docetaxel (LSAM-DTX) for local treatment of primary carcinomas with emphasis on …
and docetaxel (LSAM-DTX) for local treatment of primary carcinomas with emphasis on …
Pharmacokinetics of ciclopirox prodrug, a novel agent for the treatment of bladder cancer, in animals and humans.
SJ Weir, R Wood, MJ Baltezor, G Reed, AE Brinker… - 2019 - ascopubs.org
e14705 Background: Ciclopirox Prodrug (CPX-POM) is a novel anticancer agent currently
being evaluated in patients with advanced solid tumors participating in a First-in-Human, …
being evaluated in patients with advanced solid tumors participating in a First-in-Human, …
Preclinical development of ciclopirox prodrug for the treatment of non-muscle invasive and muscle invasive bladder cancer.
…, G Reed, AE Brinker, W McCulloch, MJ Baltezor… - 2018 - ascopubs.org
e14576 Background: Ciclopirox (CPX) is an antifungal agent contained in a number of FDA-approved
topical drug products. CPX possesses anticancer activity in a number of in vitro …
topical drug products. CPX possesses anticancer activity in a number of in vitro …
[PDF][PDF] Bench-to-bedside translation of ciclopirox prodrug for the treatment of non-muscle invasive and muscle-invasive bladder cancer
…, W McCulloch, GA Reed, A Brinker, MJ Baltezor… - Can Res, 2018 - ciclomed.com
Background & Significance Acknowledgements In Vitro Proof of Principle In Vivo Proof of
Principle Ongoing and Future Studies Page 1 1University of Kansas Medical Center, Kansas …
Principle Ongoing and Future Studies Page 1 1University of Kansas Medical Center, Kansas …
Safety, dose tolerance, pharmacokinetics and pharmacodynamics study of CPX-POM in patients with advanced solid tumors.
…, R Challenger, P Ramamoorthy, G Reed, MJ Baltezor… - 2018 - ascopubs.org
TPS2618 Background: Ciclopirox (CPX) is an antifungal agent contained in a number of
FDA-approved topical drug products. CPX possesses anticancer activity in a number of in vitro …
FDA-approved topical drug products. CPX possesses anticancer activity in a number of in vitro …
[BOOK][B] PREPARATION AND EVALUATION OF BIS-(3-CARBOXY-4-HYDROXY-1-NAPHTHYL) ALKANONES AS NOVEL COMPLEXING AGENTS. COMPLEXATION …
MJ Baltezor - 1976 - search.proquest.com
Complexation or molecular association may be defined as a weak, reversible interaction
between organic molecules. For this study, this interaction may be further classified as that …
between organic molecules. For this study, this interaction may be further classified as that …